Bill Gates has invested $50m in the corporate-backed fund, which is financing treatments and technologies to fight dementia.
Dementia Discovery Fund (DDF), a strategic investment fund backed by pharmaceutical firms Biogen, GlaxoSmithKline (GSK), Johnson & Johnson, Lilly, Pfizer and Takeda, has secured $50m ifrom Microsoft co-founder Bill Gates.
DDF, which is managed by venture capital firm SV Life Sciences, was launched in 2015 with $100m of funding from the corporates. It invests in technology that can improve the diagnosis and treatment of dementia.
The fund’s limited partners also include Astex Pharmaceuticals, a UK-based subsidiary of drug manufacturer…
